As Prices Are Slashed, Drug Makers Eye German Law

Law360, New York (November 1, 2006, 12:00 AM EST) -- A recently enacted German law has the country’s drug makers gearing up for a new round of price cuts in a move that could also have wide-ranging implications on multinational pharmaceutical companies’ bids to market medicines in Germany.

Starting on Wednesday, a new batch of prescription drugs – comprised mostly of generics but also including certain patent-protected medicines – will be subject to legislation meant to help the country trim health care spending.

The first phase of the legislation – known as the "AVWG" – went...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.